length plasmid sequencing (Eurofins)
Structured Review

Length Plasmid Sequencing, supplied by Eurofins, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/length+plasmid+sequencing/bio_rxiv__64898__2026__03__24__714005-166-12-16?v=Eurofins
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Role of a childhood cancer-linked BRIP1/FANCJ germline variant in genomic instability and cancer cell vulnerability"
Article Title: Role of a childhood cancer-linked BRIP1/FANCJ germline variant in genomic instability and cancer cell vulnerability
Journal: bioRxiv
doi: 10.64898/2026.03.24.714005
Figure Legend Snippet: a, Three-generation pedigree of an 11-year-old pediatric patient diagnosed with cancer investigated in this study. b, Whole-exome sequencing (WES) of peripheral-blood-derived DNA from the patient and both parents identified a novel missense variant in BRIP1 (c.485G>A, p.Arg162Gln) located in the nuclear localization signal (NLS), inherited from the mother, and a missense variant in HIPK2 (c.1804A>C, p.Thr602Pro), inherited from the father. c, Coomassie-stained SDS-PAGE of purified recombinant BRIP1/FANCJ WT and BRIP/FANCJ R162Q proteins. d, FAM-labeled 5’ overhang DNA substrate unwinding assay using increasing concentrations of BRIP1 WT or R162Q (1-20 nM) as indicated. Upper signal indicates the duplex substrate, the lower one the unwound FAM-labelled oligonucleotide. A representative assay is shown e, Quantification of DNA unwinding assays (n=3) shown as percentage of unwound substrate (mean ± SEM).
Techniques Used: Sequencing, Derivative Assay, Variant Assay, Staining, SDS Page, Purification, Recombinant, Labeling
Figure Legend Snippet: a, Schematic overview of the generation of HCT116 cell pools stably overexpressing BRIP1 WT or BRIP1 R162Q. BRIP1 WT or R162Q constructs contained C-terminal c-Myc and HA epitope tags. b, Representative Sanger sequencing traces confirming the presence of BRIP1 WT or BRIP1 R162Q in transduced HCT116 cells. c, d, Immunoblot analysis confirming expression of BRIP1 and Myc-tagged proteins in HCT116 cells expressing BRIP1 WT or R162Q, detected using BRIP1 and Myc antibodies. Vinculin served as a loading control. e, j, Functional characterization of HCT116 cells expressing BRIP1 WT or R162Q by colony formation assays following e, mitomycin C (MMC) (0.5;1; 2; 3; 4 μM/ml), g, ionizing radiation (IR) (2; 3; 4; 5 Gy), and j, hydroxyurea (HU) treatment 50;100;150;200;250 μM/ml). Representative colony plates (upper panels) and quantification of survival fractions (lower panels) are shown. Quantification was performed using EagleEye analysis software. Data represent the mean ± SD of three independent biological replicates.
Techniques Used: Stable Transfection, Construct, Sequencing, Western Blot, Expressing, Control, Functional Assay, Software

